Janux Therapeutics · 22 hours ago
Sr. CTM/Associate Director, Clinical Operations
Janux Therapeutics is focused on early-phase oncology studies and is seeking a Sr. CTM/Associate Director for Clinical Operations. This role involves managing operational aspects of clinical trials, overseeing external partners, and ensuring compliance with regulatory standards.
BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Lead the planning, initiation, execution, and close-out of complex Phase I oncology trials. Ensure all trial activities are conducted in accordance with the protocol, SOPs, GCP, and applicable regulations
Manage and oversee external partners including CROs, central labs, biometrics, safety vendors, eTMF providers, and others. Ensure deliverables are met on time, within budget, and to quality standards
Manage, mentor, and support direct reports, fostering professional development and team performance
Participate in site selection, feasibility assessments, and initiation visits. Build strong relationships with investigators and site staff to support efficient enrollment and high-quality data collection
Oversee the development and review of essential study documents such as protocols, informed consent forms, case report forms (CRFs), monitoring plans, and study manuals
Review monitoring reports and ensure timely resolution of issues. Provide guidance to CRO monitors and ensure appropriate sponsor oversight is documented
Conduct ongoing data reviews and support data cleaning activities. Ensure inspection readiness at all times, including regular review of the Trial Master File (TMF)
Collaborate with finance and legal teams to manage study budgets, review vendor invoices, and negotiate contracts and change orders
Work closely with internal stakeholders including Clinical Development, Regulatory Affairs, Medical Affairs, and CMC to ensure alignment and smooth execution of clinical programs
Provide guidance and mentorship to junior team members and cross-functional colleagues. Share best practices and contribute to continuous process improvement
Prepare and deliver study updates, metrics, and presentations to senior leadership. Represent Clinical Operations in internal and external meetings
Contribute to the development and implementation of SOPs, work instructions, and operational tools to enhance team efficiency and compliance
Willingness to travel up to 15% for site visits, vendor meetings, and conferences
Other activities as assigned
Qualification
Required
BA/BS in related scientific field with a minimum of 8-10 years (Sr. CTM) OR 10–12 years (Associate Director) of experience in clinical research, with at least 6 years in clinical trial management
Demonstrated experience managing early-phase oncology trials, particularly in solid tumors and immunotherapy/biologics
Proven track record of leading trials from start-up through close-out, including protocol development, site initiation, vendor management, and data review
Strong knowledge of ICH GCP, FDA regulations, and global clinical research guidelines
Proficiency in MS Office and clinical trial systems (e.g., CTMS, eTMF, EDC)
Ability to interpret and analyze clinical data and metrics
Excellent communication, leadership, and interpersonal skills
Strong organizational and time management abilities
High level of accountability, adaptability, and attention to detail
Ability to work independently and collaboratively in a fast-paced, matrixed environment
Ability to travel up to 15%
Benefits
401K
Medical insurance
Dental insurance
Vision insurance
Supplemental disability insurance plans
Flexible schedule
Life insurance
Flexible vacation
Sick time
Incentive stock option plan
Relocation assistance
Company
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Funding
Current Stage
Public CompanyTotal Funding
$898.94MKey Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M
Leadership Team
Recent News
2025-12-24
2025-12-04
2025-12-03
Company data provided by crunchbase